Earnings Insights · Colgate-Palmolive (CL) · Q3 FY2026
Colgate-Palmolive (CL) Q3 FY2026: Colgate-Palmolive Q3 2026 Earnings: Margin Resilience Offsets a Weak North American Quarter
By AlgovestIQ ResearchPublished
Read Colgate-Palmolive Company’s results announcement (Form 8-K, filed Oct 30, 2026)
Key earnings findings
Colgate-Palmolive (CL) Q3 FY2026 · results discussed on the earnings call · Form 8-K filed
- Colgate-Palmolive reported Q3 FY2026 revenue of $5.37B against the $5.34B analyst estimate, a 0.6% beat, and EPS of $0.97 against the $0.93 analyst estimate, a 4.8% beat.
- Net sales growth of 4% to 5%, narrowed from prior guidance of 2% to 6%.
- CL closed at $95.29 on Oct 30, 2026, up 2.3% from $93.16 on Oct 29, 2026, the last close before the results were released.
Sources: Colgate-Palmolive Company results announcement (SEC), the Q3 FY2026 earnings call, and AlgovestIQ reported-results and market data. All references
Did Colgate-Palmolive beat earnings expectations?
- EPS has beaten the estimate in all 8 of the most recent reported quarters on record.
- Revenue surprise across the last 8 reported quarters has ranged from -0.7% to 2.1%.
Reported figures against analyst estimates, compiled from AlgovestIQ data.
Colgate-Palmolive reported third-quarter net sales of $5.37B, up 4.6%, while diluted GAAP EPS increased 3% to $0.94. Organic sales rose 3.6%, supported by 1.7% volume growth and 2.0% pricing, while Base Business EPS increased 7% to $0.97.
The quarter reinforced the strength of Colgate’s international and Hill’s Pet Nutrition businesses, but also highlighted the need for a sustained U.S. turnaround. Gross margins improved despite elevated input and logistics costs, allowing the company to raise its full-year margin and Base Business EPS outlook while continuing to increase advertising investment.
Earnings Snapshot
| Metric | Reported | Change |
|---|---|---|
| Net sales | $5.37B | +4.6% |
| Organic sales growth | 3.6% | — |
| Volume growth | 1.7% | — |
| Pricing | 2.0% | — |
| GAAP diluted EPS | $0.94 | +3% |
| Base Business diluted EPS | $0.97 | +7% |
| GAAP gross profit margin | 60.2% | +80 bps |
| Base Business gross profit margin | 60.3% | +90 bps |
| GAAP operating profit | $1.09B | +3% |
| GAAP operating margin | 20.3% | -30 bps |
| Base Business operating margin | 20.8% | +20 bps |
| Advertising | $775M | +$101M |
| North America organic sales growth | -1.6% | — |
| Latin America organic sales growth | +6.0% | — |
| Europe, Middle East & Africa organic sales growth | +2.7% | — |
| Asia Pacific organic sales growth | +4.6% | — |
| Hill’s Pet Nutrition organic sales growth | +5.7% | — |
The Bigger Story
The central development was Colgate’s ability to expand gross margin while maintaining higher brand investment in an increasingly difficult cost environment. Management cited pricing, premium product mix, manufacturing leverage from higher volumes and productivity initiatives as offsets to inflation in resins, petrochemicals, pulp, paper, freight and logistics.
That performance enabled the company to raise its full-year gross-margin outlook from roughly flat to positive growth, despite management expecting cost pressure to peak in the fourth quarter. The improvement is important because it suggests Colgate’s pricing and productivity programs are, at least for now, offsetting inflation without requiring a retreat in advertising spending.
The unresolved issue is North America. The division represented 17% of company sales but posted a 1.6% organic sales decline, including a 3.7% volume decline. Management described its U.S. reset as a work in progress, centered on premium innovation, more targeted advertising, stronger digital and social-commerce capabilities, and changes to its commercial organization.
Revenue and Operating Performance
Organic growth was broad geographically, with growth in four of five divisions and all four product categories. Emerging markets remained the principal growth engine, with management pointing to strength in India, Brazil and China.
Latin America delivered the strongest divisional performance, with sales up 12.5% and organic sales up 6.0%. Volume increased 3.9% and pricing contributed 2.1%. Brazil posted double-digit growth, supported by premium oral-care products, advertising and gains in faster-growing personal-care categories. Mexico was weaker because of softer consumer conditions and retailer-specific challenges; management expects another difficult quarter there before those issues subside entering 2027.
Asia Pacific sales increased 3.5%, or 4.6% organically, with 1.9% volume growth and 2.8% pricing. India again grew at a double-digit rate, according to management, aided by premium innovation and expansion in modern trade and e-commerce. Greater China also grew, although management said the broader Chinese category environment remains pressured, especially in brick-and-mortar retail. Colgate’s growth there was driven by premium products, online sales, club retail and social-commerce execution.
Europe, Middle East & Africa produced 2.7% organic sales growth despite a 0.9% pricing decline. Volumes rose 3.5%, with management citing premium oral-care execution, including whitening, Colgate Total and elmex, as well as improved support for the Sanex personal-care brand. European category growth remained relatively subdued, but Colgate said it continued to gain share in premium segments.
Hill’s Pet Nutrition grew sales 5.6%, or 5.7% organically, driven by 1.8% volume growth and 3.9% pricing. Management said therapeutic products, cat food and wet food were the major contributors, while the broader pet-food category remained sluggish. Prescription Diet cat sales grew double digits, according to management, while the company also benefited from additional wet-food manufacturing capacity.
North America was the exception. Sales declined 1.7%, with organic sales down 1.6%. Pricing added 2.2%, but volumes declined 3.7%. Management said there was no meaningful retailer destocking during the quarter, implying that the decline largely reflected underlying category and competitive conditions rather than inventory movements.
Profitability and Margins
Gross profit rose to $3.23B, and the GAAP gross margin expanded 80 basis points to 60.2%. On a Base Business basis, gross margin increased 90 basis points to 60.3%.
Management said material costs remained a roughly 300-basis-point headwind to gross profit in the quarter. Productivity savings from its funding-the-growth program offset more than 290 basis points of that pressure, while pricing contributed 80 basis points and mix added roughly 20 basis points. The company also said an insignificant tariff refund was received during the quarter and was not a meaningful driver of margin performance.
Operating-margin results were more mixed. GAAP operating profit increased 3% to $1.09B, but the GAAP operating margin declined 30 basis points to 20.3%. Selling, general and administrative expenses increased to 39.3% of sales from 38.4%, reflecting greater advertising spending and other investments.
Base Business operating profit increased 5% to $1.12B, and the Base Business operating margin rose 20 basis points to 20.8%. The difference between GAAP and Base Business results was primarily related to $29M of charges under the Strategic Growth and Productivity Program.
Hill’s operating profit rose 5% to $267M, though its operating margin declined 20 basis points to 22.2%. Management attributed the modest margin decline to investment behind advertising, innovation and the initial rollout of its Fresh product line rather than a deterioration in underlying gross profitability.
Demand, Customers and Pricing
Colgate generated 2.0% pricing growth companywide in the quarter, broadly consistent with the first half’s pricing cadence. Management said pricing has been supported by several revenue-growth-management levers, including list prices, premium innovation, price-pack architecture and promotion optimization.
The company expects the industry’s elevated cost base to require further pricing actions, though management indicated the approach will vary by market and category. In developed markets, premium innovation may account for more of the pricing contribution, while emerging markets may offer greater opportunity for list-price actions.
Management said global category growth is running at roughly 1.5% to 3%, with emerging markets growing about 3% to 5% and developed markets closer to 1.5% to 2%. North America remains the most pressured developed market, while Europe is broadly flat.
Colgate maintained leading global year-to-date market shares of 41.4% in toothpaste and 33.1% in manual toothbrushes. Management said oral-care shares also improved during the quarter across toothpaste, toothbrushes and mouthwash.
What is Colgate-Palmolive’s guidance for full-year 2026?
Based on current spot rates, Colgate now expects:
- Net sales growth of 4% to 5%, narrowed from prior guidance of 2% to 6%. The outlook includes a low-single-digit positive foreign-exchange impact.
- Organic sales growth broadly in line with nine-month performance, versus prior guidance of 1% to 4%. Organic sales grew 3.0% through the first nine months of 2026.
- GAAP gross profit margin to increase, compared with prior expectations for roughly flat performance.
- Advertising to increase both in dollars and as a percentage of sales.
- GAAP EPS growth of double digits.
- Base Business gross profit margin to increase, also improved from roughly flat prior expectations.
- Base Business EPS growth of 5% to 7%, raised from previous guidance for mid-single-digit growth.
Management said its commodity costs for the fourth quarter are largely locked in and incorporated into guidance. However, it expects raw-material, freight and logistics pressure to remain elevated through year-end and into early 2027. Management also expects tariffs to peak in the fourth quarter and said foreign exchange has recently moved unfavorably.
Balance Sheet, Cash Flow and Capital
For the first nine months, net cash provided by operations increased to $2.91B from $2.75B. Free cash flow before dividends rose 7% to $2.51B, after $400M of capital expenditures.
Colgate returned $2.24B to shareholders through $1.31B in dividends and $927M of share repurchases. Total debt declined to $7.72B at September 30 from $7.99B at year-end 2025. Debt less cash, cash equivalents and marketable securities declined to $6.10B from $6.59B.
Cash and cash equivalents increased to $1.53B from $1.29B at the end of 2025. The company’s positive operating cash flow and reduced net debt provide flexibility to continue funding brand investment, productivity programs, dividends and buybacks, although its balance sheet remains meaningfully leveraged relative to its $288M of attributable shareholders’ equity.
What Investors Should Watch
1. North American volume and market-share recovery
North America’s 3.7% volume decline was the quarter’s clearest operating weakness. Investors should watch whether the planned premium innovation, revamped go-to-market structure and increased advertising support translate into sustained category share gains and a return to organic growth.
2. Pricing durability as costs remain elevated
Pricing added 2.0% to company growth and helped support gross-margin expansion. The next test is whether Colgate can maintain appropriate pricing and mix without further volume pressure, especially in developed markets where consumer demand is softer.
3. Hill’s growth beyond the core therapeutic franchise
Hill’s continues to outperform the broader pet-food category, with growth in therapeutic, cat and wet-food products. Its Fresh rollout could become an additional growth vector, but management characterized it as a deliberate, gradual launch rather than a near-term material contributor.
4. Productivity delivery and reinvestment discipline
The Strategic Growth and Productivity Program is supporting gross margin and SG&A efficiency while funding more advertising, AI, data and innovation investments. Investors should monitor whether those savings continue to offset commodity and logistics inflation without creating a larger operating-expense burden.
5. Latin America and China resilience
Latin America remains a major growth contributor, but Mexico has softened and currency volatility remains a risk. In China, Colgate’s premium and digital execution is helping offset weak physical retail, but broader consumer demand has not yet materially improved.
AlgovestIQ Takeaway
Colgate delivered a solid quarter: organic growth accelerated to 3.6%, volume remained positive globally, gross margin expanded, and Base Business EPS grew faster than sales. The company’s international footprint and Hill’s Pet Nutrition franchise continue to provide resilience, particularly as premium innovation and digital commerce gain traction in markets such as India, Brazil, China and Europe.
The most notable financial positive was margin performance. Colgate improved gross margin despite material-cost inflation and higher logistics expenses, then raised its full-year gross-margin outlook. That outcome indicates that pricing, premium mix and productivity are working together effectively enough to preserve investment in advertising and innovation.
Still, the U.S. business remains the central execution issue. North American organic sales declined, and volume fell sharply despite positive pricing. Management’s strategy addresses the right areas—premium innovation, commercial execution, targeted media and digital capabilities—but the financial evidence of a turnaround remains limited.
The investment question is therefore whether Colgate can sustain global growth and margin expansion while restoring North American volumes. Continued Hill’s momentum, resilient emerging-market demand and further productivity savings would strengthen that case. Persistent North American weakness, greater pricing-related volume pressure, or a sharper-than-expected rise in commodity and logistics costs would weaken it.
How did CL stock react?
CL closed at $95.29 on Oct 30, 2026, up 2.3% from $93.16 on Oct 29, 2026, the last close before the results were released.
| Session | Close | Change |
|---|---|---|
| Oct 29, 2026 (before release) | $93.16 | — |
| Oct 30, 2026 | $95.29 | +2.3% |
| Nov 2, 2026 | $97.43 | +4.6% |
Closing prices from AlgovestIQ market data. A move around a report also reflects the wider market.
More from this earnings season
- ELFe.l.f. Beauty Q2 FY2027 Earnings: Growth Reaccelerates as rhode and International Expansion Lift OutlookNov 4, 2026
- PGProcter & Gamble Q1 FY2027 Earnings: Volume-Led Sales Growth Meets Rising Cost PressureOct 22, 2026
- MOAltria Q3 2026 Earnings: Raised EPS Outlook Offsets Pressure in Oral TobaccoOct 29, 2026
- MDLZMondelēz Q3 2026 Earnings: Volume Growth Returns as Lower Input Costs Lift MarginsOct 29, 2026
- HSYHershey Q3 2026 Earnings: Margin Recovery Offsets Weak Organic VolumeOct 29, 2026
References
- Management commentary, analyst questions and outlook discussed on the call. Source: Colgate-Palmolive Company Q3 FY2026 earnings call transcript, as of Oct 30, 2026.
- Reported results, segment figures and guidance from the company's results announcement. Source: Colgate-Palmolive Company Form 8-K, Item 2.02 (SEC EDGAR), as of Oct 30, 2026.
- Reported revenue and EPS against analyst estimates, and the reported quarterly series. Source: AlgovestIQ reported-results data, as of Oct 30, 2026.
AI-generated analysis based on company-reported earnings data and earnings-call materials. Every reported figure is checked against Colgate-Palmolive's earnings release and call transcript before publication. Not investment advice.